Artificial Intelligence and Longevity | Ali Mostashari & Martin Alexander Gershon

At the Global AI Conference hosted by One Artificial Intelligence, Dr. Ali Mostashari, CEO of LifeNome, and Dr. Martin Alexander Gershon, Managing Partner & Chief Investment Officer at Endeavor Venture Fund & Venture Studio, discuss AI's potential in extending human longevity. They highlight AI's role in redefining longevity to include both lifespan and healthspan, enabling early disease detection and personalized health strategies. AI-driven research in longevity focuses on identifying biomarkers and assessing the effectiveness of anti-aging products. This session underscores AI's transformative impact on healthcare, promising healthier, longer lives through personalized, data-driven interventions.